Altered B-cell, plasma cell, and antibody immune profiles in blood of patients with systemic mastocytosis
Journal of Allergy and Clinical Immunology · 2025
DOI: 10.1016/j.jaci.2024.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025. Verfasst von Alba Pérez-Pons und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Sal…. Hauptthemen laut MEDLINE: Mastocytosis, Systemic, Plasma Cells, B-Lymphocytes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, European Social Fund Plus, Instituto de Salud Carlos III.
Abstract (Originalsprache)
BACKGROUND: Systemic mastocytosis (SM) is a heterogeneous disease characterized by an expansion of KIT-mutated constitutively activated mast cells (MCs) that release MC mediators, which might act on the tumor microenvironment including other immune cells. OBJECTIVE: To investigate the blood distribution of B-cell, plasma cell (PC), and antibody isotype compartments in patients with SM. METHODS: We used spectral flow cytometry and the EuroFlow Immunomonitoring panel and Lymphocyte Screening Tube to quantify B cells, PCs, and their subsets in blood of 108 patients with SM (35 bone marrow mastocytosis [BMM] cases, 64 indolent SM [ISM] cases, 9 aggressive SM [ASM] cases) versus 117 age-matched healthy donors and paired bone marrow samples of 31 patients with SM versus 17 controls, respectively. In parallel, IgM, IgD, IgG, IgA, and IgE plasma levels were measured. RESULTS: Compared with healthy donors, patients with SM showed increased immature B-cell production in bone marrow (P = .003) associated with greater release of pre-germinal center immature (P < .001) and naive CD5+ B lymphocytes (P < .001) to blood, but a pronounced decrease in PC counts of all different IgH isotypes and subclasses (P ≤ .001) together with overall increased IgM (P = .001) and IgD (P < .001) plasma levels. Different immune profiles were found per diagnostic subtype of disease with progressively greater counts in blood of immature B lymphocytes together with decreased IgMD+, IgG2+, IgA1+, and IgA2+ memory B cells (P ≤ .032) and elevated IgM (P = .017) plasma levels in cases of ASM, increased IgM (P = .001) and IgD (P = .001) plasma levels in ISM cases, and exacerbated IgE (P < .001) with decreased IgG (P = .008) plasma levels in BMM cases. CONCLUSIONS: Our results reveal a significant dysregulation of the B-cell and PC compartments in blood of patients with SM, consistent with distinctly altered antibody isotype profiles in plasma of patients with BMM versus ISM versus ASM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Biomedical Research Networking Center Consor…
- Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Toledo and Madrid, Spain.
- Department of Biochemistry, University Hospital of Salamanca, Salamanca, Spain.
- Biomedical Research Networking Center Consortium, Madrid, Spain; Spanish Network on Mastocytosis, Toledo and Salamanca, Spain; Instituto de Estudios de Mastocitosis de Castilla La Mancha, Virgen del Valle Hospital, Tole…
- Cytognos SL, Salamanca, Spain.
- Cancer Research Center, Department of Medicine and Cytometry Service, University of Salamanca, Salamanca, Spain; Biomedical Research Institute of Salamanca, Salamanca, Spain; Spanish Network on Mastocytosis, Toledo and…
Förderung
- European Commission
- European Social Fund Plus
- Instituto de Salud Carlos III
- Federación Española de Enfermedades Raras
- CIBERONC
- España Ministerio de Ciencia Innovación y Universidades
- European Regional Development Fund
Zitieren
APA
Pérez-Pons, A., Henriques, A., Contreras Sanfeliciano, T., Jara-Acevedo, M., Navarro-Navarro, P., García-Montero, A. C., Álvarez-Twose, I., Lecrevisse, Q., Fluxa, R., Sánchez-Muñoz, L., Caldas, C., Pozo, J., González-López, Ó., Pérez-Andrés, M., Mayado, A., & Orfao, A. (2025). Altered B-cell, plasma cell, and antibody immune profiles in blood of patients with systemic mastocytosis. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2024.10.005
Vancouver
Pérez-Pons A, Henriques A, Contreras Sanfeliciano T, Jara-Acevedo M, Navarro-Navarro P, García-Montero AC, et al. Altered B-cell, plasma cell, and antibody immune profiles in blood of patients with systemic mastocytosis. Journal of Allergy and Clinical Immunology. 2025. doi:10.1016/j.jaci.2024.10.005
BibTeX
@article{PrezPons2025,
author = {Pérez-Pons, Alba and Henriques, Ana and Contreras Sanfeliciano, Teresa and Jara-Acevedo, María and Navarro-Navarro, Paula and García-Montero, Andrés C and Álvarez-Twose, Iván and Lecrevisse, Quentin and Fluxa, Rafael and Sánchez-Muñoz, Laura and Caldas, Carolina and Pozo, Julio and González-López, Óscar and Pérez-Andrés, Martín and Mayado, Andrea and Orfao, Alberto},
title = {Altered B-cell, plasma cell, and antibody immune profiles in blood of patients with systemic mastocytosis},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
doi = {10.1016/j.jaci.2024.10.005}
}
EUVIMED